Carfilzomib-d<sub>8</sub>

Carfilzomib-d8

CAT N°: 22558
Price:

From 237.00 201.45

Carfilzomib-d8 is intended for use as an internal standard for the quantification of carfilzomib (Item No. 17554) by GC- or LC-MS. Carfilzomib is an irreversible proteosome inhibitor classified as a peptide epoxyketone. It targets the chymotrypsin-like ?5 subunit of the constitutive 20S proteasome (IC50 = 5.2 nM) and the ?5i subunit of the immunoproteasome 20Si (LMP7; IC50 = 14 nM) with minimal cross reactivity to other proteases.{28244,28242} It can induce cell cycle arrest and apoptosis in human cancer cell lines including multiple myeloma, lymphoma, and various solid tumors (IC50s = 2.4-20 nM).{25593,28537}

We also advise you